TECH Bio-Techne Corporation
Healthcare$47.97-0.50%ClosedMarket Cap: $7.51B
As of 2026-05-26
Valuation
P/E (TTM)
103.84
PEG
—
P/B
3.60
P/S
6.23
EV/EBITDA
29.45
DCF Value
$22.08
FCF Yield
3.6%
Div Yield
0.7%
Margins & Returns
Gross Margin
65.0%
Operating Margin
12.7%
Net Margin
9.0%
ROE
5.5%
ROA
4.3%
ROIC
4.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $311.4M | 66.9% | $75.5M | $51.1M | $— | $0.08 |
| Q2 null | $295.9M | 64.6% | $54.5M | $38.0M | $— | $0.08 |
| Q1 null | $286.6M | 65.6% | $47.7M | $38.2M | $— | $0.08 |
| Q4 null | $317.0M | 62.7% | $-23.9M | $-17.7M | $— | $0.08 |
| FY null | $1.22B | 64.8% | $102.3M | $73.4M | $— | $0.32 |
| Q3 null | $316.2M | 67.9% | $38.7M | $22.6M | $— | $0.08 |
| Q2 null | $297.0M | 65.3% | $47.4M | $34.9M | $— | $0.08 |
| Q1 null | $289.5M | 63.2% | $40.0M | $33.6M | $— | $0.08 |
| Q4 null | $306.1M | 66.4% | $45.8M | $40.6M | $— | $0.08 |
| FY null | $1.16B | 66.4% | $206.7M | $168.1M | $— | $0.32 |
| Q3 null | $303.4M | 67.4% | $67.0M | $49.1M | $— | $0.08 |
| Q2 2024 | $272.6M | 64.8% | $38.0M | $27.5M | $0.17 | $0.08 |